Bruce A. Posner

Enhanced HTS Hit Selection via a Local Hit Rate Analysis

James E. J. Mills, Bruce A. Posner, Hualin Xi, 2009, J. Chem. Inf. Model..

Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells

Bruce A. Posner, Satwik Rajaram, Kevin Thurley, 2016, Nature Communications.

Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer

Michael Peyton, John D. Minna, Kakajan Komurov, 2013, Cell.

Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines

Bruce A. Posner, Steven J. Altschuler, Lani F. Wu, 2015, Nature Biotechnology.

Transforming Big Data into Cancer-Relevant Insight: An Initial, Multi-Tier Approach to Assess Reproducibility and Relevance

Ken Chen, Chris Sander, Olivier Gevaert, 2016, Molecular Cancer Research.

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

John D. Minna, Jaime Rodriguez-Canales, Bruce A. Posner, 2016, Nature.

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer

Michael Peyton, John D. Minna, Donna M. Muzny, 2018, Cell.